生物制剂在狼疮肾炎治疗中的应用
<正>一、狼疮肾炎治疗的演变和局限系统性红斑狼疮(systemic lupus erythematosus,SLE)是自身免疫介导的,以免疫性炎症为突出表现的弥漫性结缔组织病。血清抗核抗体为代表的多种自身抗体阳性和多系统受累是SLE的主要临床特征。狼疮肾炎(lupus nephritis,LN)是SLE临床最常见的严重并发症。诊断SLE时50%伴有肾脏损害,而在SLE整体病程中超过60%的成人和超...
Saved in:
| Main Author: | 胡章学 |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2015-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57920142&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
新型生物制剂用于狼疮肾炎治疗的研究进展
by: 李若熙, et al.
Published: (2024-01-01) -
巨噬细胞移动抑制因子在狼疮性肾炎中的表达
Published: (1998-01-01) -
狼疮性肾炎治疗的研究进展
by: 娄美玉, et al.
Published: (2016-01-01) -
狼疮肾炎靶向B细胞治疗研究新进展
by: 田贵青, et al.
Published: (2024-01-01) -
贝利尤单抗治疗狼疮肾炎的临床观察
by: 柯琳, et al.
Published: (2023-01-01)